Ayala Pharmaceuticals, Inc. (ADXS)
(Delayed Data from OTC)
$0.25 USD
-0.02 (-7.41%)
Updated Jun 7, 2024 02:16 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Ayala Pharmaceuticals, Inc. [ADXS]
Reports for Purchase
Showing records 41 - 60 ( 96 total )
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Strong Latin American Partnership Opens New Opportunities; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Clinical Hold Lifted; Expect Little Impact on Study Results; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Lm is Unlikely Cause of Patient''s Death; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Stellar GOG0265 Results Pave the Way for AIM2CERV; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Advaxis Entering a Data-Laden Period Beginning This Week; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Full Steam Ahead in Clinical Programs; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Management Executing on Plan; Fundamentals Remain Strong; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Clinical Programs in Full Swing; New $30 Price Target; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Immunotherapy Revolution Marches On; Impressions From ASCO 2015
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
2015 ASCO Planner-Clinical Data to Keep -Da Bears- AwayThis report contains brief updates on the following: ADXS, AGEN, ARIA, CLSN, CTIC, HTBX, ONTY, SGEN, SPPI, STML, TGTX, THLD. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: BENJAMIN R
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
On the Road to Curing Cancer: Recent Developments and Future Outlook
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Playing Games with Russell; Annual Index Manipulations May Create Opportunities
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: DEDE K
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Combining Immunotherapy Platforms to Maximize Potential
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Data at AACR Underscores the Utility of Lm-LLO as Cancer Immunotherapy; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Advancing Programs Highlight Growth Potential; New $25 Price Target; Reiterate Buy
Provider: H.C. WAINWRIGHT & CO., INC.
Analyst: RAMAKANTH S
Company: Ayala Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: ZENG G